These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7471860)

  • 21. [Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol].
    Kuŝić M; Gavrilović M; Mihajloviĉ M; Boŝković B
    Srp Arh Celok Lek; 1980 Sep; 108(9):875-81. PubMed ID: 7302695
    [No Abstract]   [Full Text] [Related]  

  • 22. "Low dose" colestipol in children, adolescents and young adults with familial hypercholesterolemia.
    Schlierf G; Mrozik K; Heuck CC; Middelhoff G; Oster P; Riesen W; Schellenberg B
    Atherosclerosis; 1982 Jan; 41(1):133-8. PubMed ID: 7073790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined therapy of niacin, colestipol, and fat-controlled diet in men with coronary bypass. Effect on blood lipids and apolipoproteins.
    Nessim SA; Chin HP; Alaupovic P; Blankenhorn DH
    Arteriosclerosis; 1983; 3(6):568-73. PubMed ID: 6651612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diet, drugs, and plasma exchange in the treatment of hyperlipidemia in childhood.
    Mancini M; Postiglione A; Farinaro E; Montefusco S
    Prev Med; 1983 Nov; 12(6):848-53. PubMed ID: 6676732
    [No Abstract]   [Full Text] [Related]  

  • 25. Primary hypercholesterolemia: effect of treatment on serum lipids, lipoprotein fractions, cholesterol absorption, sterol balance, and platelet aggregation.
    Briones ER; Steiger D; Palumbo PJ; Kottke BA
    Mayo Clin Proc; 1984 Apr; 59(4):251-7. PubMed ID: 6708603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)].
    Briani G; Fellin R; Balestrieri P; Baggio G; Baiocchi MR; Crepaldi G
    G Ital Cardiol; 1975; 5(3):390-404. PubMed ID: 1149965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up.
    Ojala JP; Helve E; Karjalainen K; Tarkkanen A; Tikkanen MJ
    Atherosclerosis; 1990 May; 82(1-2):85-95. PubMed ID: 2360923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of colestipol on plasma lipids in patients affected by type Ii primary hyperlipoproteinaemia (author's transl)].
    Drouin P; Sauvanet JP; Lambert D; Mejean L; Debry G
    Therapie; 1980; 35(4):457-64. PubMed ID: 7466730
    [No Abstract]   [Full Text] [Related]  

  • 29. Importance of diet in the treatment of familial hypercholesterolemia.
    Connor WE; Connor SL
    Am J Cardiol; 1993 Sep; 72(10):42D-53D. PubMed ID: 8213496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probucol with colestipol in the treatment of hypercholesterolemia.
    Dujovne CA; Krehbiel P; Decoursey S; Jackson B; Chernoff SB; Pitterman A; Garty M
    Ann Intern Med; 1984 Apr; 100(4):477-82. PubMed ID: 6367578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia.
    Malloy MJ; Kane JP; Kunitake ST; Tun P
    Ann Intern Med; 1987 Nov; 107(5):616-23. PubMed ID: 3662275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of colestipol therapy in Type II hyperlipoproteinemia.
    Lees AM; McCluskey MA; Lees RS
    Atherosclerosis; 1976; 24(1-2):129-40. PubMed ID: 182181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
    Bilheimer DW; Grundy SM; Brown MS; Goldstein JL
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4124-8. PubMed ID: 6575399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term response to dietary counseling of hyperlipidemic outpatients of a lipid clinic.
    Dallongeville J; Leboeuf N; Blais C; Touchette J; Gervais N; Davignon J
    J Am Diet Assoc; 1994 Jun; 94(6):616-21. PubMed ID: 8195548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy of familial and acquired hyperlipoproteinemia in children and adolescents.
    Glueck CJ
    Prev Med; 1983 Nov; 12(6):835-47. PubMed ID: 6676731
    [No Abstract]   [Full Text] [Related]  

  • 36. The familial hypercholesterolemia regression study: a randomized comparison of therapeutic reduction of both low-density lipoprotein and lipoprotein(a) versus low-density lipoprotein alone.
    Kitano Y; Thompson GR
    Ther Apher; 1997 May; 1(2):187-90. PubMed ID: 10225769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia.
    Glueck CJ; Mellies MJ; Dine M; Perry T; Laskarzewski P
    Pediatrics; 1986 Aug; 78(2):338-48. PubMed ID: 3526270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy of hyperlipidemic states.
    Havel RJ; Kane JP
    Annu Rev Med; 1982; 33():417-33. PubMed ID: 7044276
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia.
    Hoogwerf BJ; Peters JR; Frantz ID; Hunninghake DB
    Metabolism; 1985 Oct; 34(10):978-81. PubMed ID: 4046841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.
    Brown G; Albers JJ; Fisher LD; Schaefer SM; Lin JT; Kaplan C; Zhao XQ; Bisson BD; Fitzpatrick VF; Dodge HT
    N Engl J Med; 1990 Nov; 323(19):1289-98. PubMed ID: 2215615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.